Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: A CLARITY-TIMI 28 analysis

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 4, 2011, Pages 493-500

  Ahmed, Shaheeda ^a   Gibson, C Michael ^a   Cannon, Christopher P ^a   Murphy, Sabina A ^a   Sabatine, Marc S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fibrinolysis; Glomerular filtration rate; Myocardial infarction; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CREATININE; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING DISORDER; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; ADOLESCENT; AGED; BLEEDING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FIBRINOLYTIC THERAPY; HEART INFARCTION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYSIS; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; THROMBOLYTIC THERAPY; TICLOPIDINE;

EID: 80052307349     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0566-9     Document Type: Article

References (21)

1. Anavekar NS, McMurray JJ, Velazquez EJ et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351(13):1285-1295 (Pubitemid 39258422)
2. Gibson CM, Pinto DS, Murphy SA et al (2003) Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42(9):1535-1543 (Pubitemid 37378428)
3. Boccardo P, Remuzzi G, Galbusera M (2004) Platelet dysfunction in renal failure. Semin Thromb Hemost 30(5):579-589 (Pubitemid 39426390)
4. Gawaz MP, Dobos G, Spath M, Schollmeyer P, Gurland HJ, Mujais SK (1994) Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 5(1):36-46 (Pubitemid 24977057)
5. Sagripanti A, Barsotti G (1997) Bleeding and thrombosis in chronic uremia. Nephron 75(2):125-139 (Pubitemid 27064854)
6. Gibson CM, Dumaine RL, Gelfand EV et al (2004) Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13, 307 patients in five TIMI trials. Eur Heart J 25(22):1998-2005 (Pubitemid 39486018)
7. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA (2003) Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 41(5):718-724 (Pubitemid 36308375)
8. Sabatine MS, Cannon CP, Gibson CM et al (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352(12): 1179-1189 (Pubitemid 40397259)
9. Sabatine MS, McCabe CH, Gibson CM, Cannon CP (2005) Design and rationale of clopidogrel as adjunctive reperfusion therapy-thrombolysis in myocardial infarction (CLARITY-TIMI) 28 trial. Am Heart J 149(2):227-233 (Pubitemid 40348527)
10. K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 39(2 Suppl 1):S1-266
11. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139(2): 137-147
12. Al Suwaidi J, Reddan DN, Williams K et al (2002) Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106(8):974-980 (Pubitemid 34925333)
13. Angiolillo DJ, Bernardo E, Capodanno D et al (2010) Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 55(11):1139-46
14. Angiolillo DJ, Bernardo E, Sabate M et al (2007) Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 50(16):1541-1547 (Pubitemid 47532327)
15. Kirtane AJ, Vafai JJ, Murphy SA et al (2006) Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy. Eur Heart J 27(17):2040-2045 (Pubitemid 44412807)
16. Appelbaum E, Kirtane AJ, Clark A et al (2009) Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction. J Thromb Thrombolysis 27(2):123-129
17. Gibson CM, Cannon CP, Murphy SA et al (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101(2):125-130 (Pubitemid 30044249)
18. Keltai M, Tonelli M, Mann JF et al (2007) Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 14(2):312-318 (Pubitemid 46650089)
19. Gibson CM, Pride YB, Frederick PD et al (2008) Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 156(6): 1035-1044
20. Widimsky P, Wijns W, Fajadet J et al (2010) Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 31(8):943-57
21. Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108(17):2154-2169 (Pubitemid 37337595)